December 17, 2018
Genetics Signatures (ASX:GSS) CE-IVD Mark for Respiratory Pathogen Detection Kit
October 28, 2019
Genetic Signatures Ltd Completes $35m Placement
Company has raised $35m through a placement to institutional and sophisticated investors. Cornerstone investors include Perennial Value Management and Regal Funds Management plus a large global funds manager. The placement at $0.98 per share was a 9.3% discount to last closing price.
Non-Executive Director Retirement
Non-executive director, Mr Phillip Isaacs, has advised he will retire from the Board t the conclusion of the 2019 Annual General Meeting
$A2.1m R&D Rebate Received
Company received its rebate from the Australia Tax Office for the 2019 financial year
November 19, 2019
Successful Completion of Share Purchase Plan
SPP closed on 15 November 2019 significantly oversubscribed.